Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,957,985
-$4,587,114 QoQ
Shares Held
435,639
-32.9% QoQ
Ownership
0.555%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. CRMD ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,957,985 | 435,639 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,545,099 | 648,762 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,810,726 | 843,571 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $9,452,555 | 767,253 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,335,035 | 703,740 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,230,674 | 398,849 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,766,475 | 342,386 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,175,431 | 271,463 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $830,836 | 195,953 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $943,657 | 250,973 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $487,291 | 131,701 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $760,066 | 191,453 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $520,256 | 123,284 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $353,162 | 124,793 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,072,863 | 266,882 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,204,781 | 219,851 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $693,513 | 152,421 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,709,746 | 367,688 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,082,866 | 303,625 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,829,676 | 283,251 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $288,335 | 38,807 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $243,490 | 40,380 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $70,131 | 11,132 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $58,225 | 16,219 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||